You have free access to this content

Hepatology

Cover image for Vol. 59 Issue 6

June 2014

Volume 59, Issue 6

Pages 2059–2429

  1. Hepatology Highlights

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Hepatology highlights (pages 2059–2061)

      Jean-François Dufour

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27166

  2. Editorials

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Obeticholic acid: A new light in the shadows treating portal hypertension? (pages 2072–2073)

      Jordi Gracia-Sancho, Virginia Hernández-Gea and Juan Carlos Garcia-Pagán

      Version of Record online: 28 APR 2014 | DOI: 10.1002/hep.27027

    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
  3. Rapid Communication

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection (pages 2083–2091)

      Hiromitsu Kumada, Yoshiyuki Suzuki, Kenji Ikeda, Joji Toyota, Yoshiyasu Karino, Kazuaki Chayama, Yoshiiku Kawakami, Akio Ido, Kazuhide Yamamoto, Koichi Takaguchi, Namiki Izumi, Kazuhiko Koike, Tetsuo Takehara, Norifumi Kawada, Michio Sata, Hidetaka Miyagoshi, Timothy Eley, Fiona McPhee, Andrew Damokosh, Hiroki Ishikawa and Eric Hughes

      Version of Record online: 1 APR 2014 | DOI: 10.1002/hep.27113

  4. Viral Hepatitis

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study (pages 2092–2100)

      Chiun Hsu, Hsiao-Hui Tsou, Shyh-Jer Lin, Ming-Chung Wang, Ming Yao, Wen-Li Hwang, Woei-Yau Kao, Chang-Fang Chiu, Sheng-Fung Lin, Johnson Lin, Cheng-Shyong Chang, Hwei-Fang Tien, Tsang-Wu Liu, Pei-Jer Chen, Ann-Lii Cheng and on behalf of the Taiwan Cooperative Oncology Group

      Version of Record online: 14 APR 2014 | DOI: 10.1002/hep.26718

    2. You have free access to this content
      Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin (pages 2101–2109)

      Teresa Santantonio, Massimo Fasano, Evangelista Sagnelli, Paolo Tundo, Sergio Babudieri, Paolo Fabris, Mario Toti, Giovanni Di Perri, Nicoletta Marino, Eligio Pizzigallo, Gioacchino Angarano and the Acute Hepatitis C Study Group

      Version of Record online: 29 APR 2014 | DOI: 10.1002/hep.26991

    3. You have free access to this content
      Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo (pages 2110–2120)

      Marianna Hösel, Julie Lucifora, Thomas Michler, Gisela Holz, Marion Gruffaz, Stephanie Stahnke, Fabien Zoulim, David Durantel, Mathias Heikenwalder, Dirk Nierhoff, Rachel Millet, Anna Salvetti, Ulrike Protzer and Hildegard Büning

      Version of Record online: 30 APR 2014 | DOI: 10.1002/hep.26990

    4. You have free access to this content
      Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver (pages 2121–2130)

      Stefan Wieland, Zuzanna Makowska, Benedetta Campana, Diego Calabrese, Michael T. Dill, Josan Chung, Francis V. Chisari and Markus H. Heim

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.26770

    5. You have free access to this content
      Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3 (pages 2131–2139)

      Karolina Rembeck, Jesper Waldenström, Kristoffer Hellstrand, Staffan Nilsson, Kristina Nyström, Anna Martner, Magnus Lindh, Gunnar Norkrans, Johan Westin, Court Pedersen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Kristine Mørch, Peer Brehm Christensen and Martin Lagging

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.27009

    6. You have free access to this content
      Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses (pages 2140–2151)

      William O. Osburn, Anna E. Snider, Brittany L. Wells, Rachel Latanich, Justin R. Bailey, David L. Thomas, Andrea L. Cox and Stuart C. Ray

      Version of Record online: 29 APR 2014 | DOI: 10.1002/hep.27013

    7. You have free access to this content
      ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response (pages 2152–2160)

      Jacinta A. Holmes, Stuart K. Roberts, Rachel J. Ali, Gregory J. Dore, William Sievert, Geoffrey W. McCaughan, Darrell H. Crawford, Wendy S. Cheng, Martin D. Weltman, Sara Bonanzinga, Kumar Visvanathan, Vijaya Sundararajan, Paul V. Desmond, D. Scott Bowden, Gail V. Matthews, Alexander J. Thompson and on behalf of the CHARIOT Study Group

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.27022

    8. You have free access to this content
      Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens (pages 2161–2169)

      Zobair M. Younossi, Maria Stepanova, Fatema Nader, Ira M. Jacobson, Ed Gane, David Nelson, Eric Lawitz and Sharon L. Hunt

      Version of Record online: 30 APR 2014 | DOI: 10.1002/hep.27161

  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data (pages 2170–2177)

      Eric Trépo, Pierre Nahon, Gianluca Bontempi, Luca Valenti, Edmondo Falleti, Hans-Dieter Nischalke, Samia Hamza, Stefano Ginanni Corradini, Maria Antonella Burza, Erwan Guyot, Benedetta Donati, Ulrich Spengler, Patrick Hillon, Pierluigi Toniutto, Jean Henrion, Denis Franchimont, Jacques Devière, Philippe Mathurin, Christophe Moreno, Stefano Romeo and Pierre Deltenre

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.26767

    2. You have free access to this content
      Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis (pages 2178–2187)

      Fernando Bril, Romina Lomonaco, Beverly Orsak, Carolina Ortiz-Lopez, Amy Webb, Fermin Tio, Joan Hecht and Kenneth Cusi

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.26988

    3. You have free access to this content
    4. You have free access to this content
      CLOCK/BMAL1 regulates circadian change of mouse hepatic insulin sensitivity by SIRT1 (pages 2196–2206)

      Ben Zhou, Yi Zhang, Fang Zhang, Yulei Xia, Jun Liu, Rui Huang, Yuangao Wang, Yanan Hu, Jingxia Wu, Changgui Dai, Hui Wang, Yanyang Tu, Xiaozhong Peng, Yiqian Wang and Qiwei Zhai

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.26992

  6. Hepatobiliary Malignancies

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly (pages 2207–2215)

      Chien-Hsieh Chiang, Long-Teng Lee, Shou-Hung Hung, Wen-Yuan Lin, Hui-Fang Hung, Wei-Shiung Yang, Pei-Kun Sung and Kuo-Chin Huang

      Version of Record online: 3 APR 2014 | DOI: 10.1002/hep.27014

    2. You have free access to this content
      Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing (pages 2216–2227)

      Jia-Hao Jiang, Yan-Feng Liu, Ai-Wu Ke, Fang-Ming Gu, Yao Yu, Zhi Dai, Qiang Gao, Guo-Ming Shi, Bo-Yi Liao, You-Hua Xie, Jia Fan, Xiao-Wu Huang and Jian Zhou

      Version of Record online: 2 MAY 2014 | DOI: 10.1002/hep.27012

    3. You have free access to this content
      Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature (pages 2228–2237)

      Gabriel G. Malouf, Sylvie Job, Valérie Paradis, Monique Fabre, Laurence Brugières, Pierre Saintigny, Laure Vescovo, Jacques Belghiti, Sophie Branchereau, Sandrine Faivre, Aurélien de Reyniès and Eric Raymond

      Version of Record online: 30 APR 2014 | DOI: 10.1002/hep.27018

    4. You have free access to this content
      Functional genomics identified a novel protein tyrosine phosphatase receptor type f-mediated growth inhibition in hepatocarcinogenesis (pages 2238–2250)

      Rabindranath Bera, Chih-Yung Chiou, Ming-Chin Yu, Jei-Ming Peng, Chung-Ru He, Chih-Yun Hsu, Hsiao-Ling Huang, Uda Y. Ho, Shi-Ming Lin, Yu-Jr Lin and Sen-Yung Hsieh

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.27030

    5. You have free access to this content
      Epigenetic reprogramming modulates malignant properties of human liver cancer (pages 2251–2262)

      Chiara Raggi, Valentina M. Factor, Daekwan Seo, Agnes Holczbauer, Matthew C. Gillen, Jens U. Marquardt, Jesper B. Andersen, Marian Durkin and Snorri S. Thorgeirsson

      Version of Record online: 1 MAY 2014 | DOI: 10.1002/hep.27026

  7. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis (pages 2263–2275)

      James H. Tabibian, Steven P. O'Hara, Patrick L. Splinter, Christy E. Trussoni and Nicholas F. LaRusso

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.26993

  8. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Idiopathic portal hypertension: Natural history and long-term outcome (pages 2276–2285)

      Sith Siramolpiwat, Susana Seijo, Rosa Miquel, Annalisa Berzigotti, Angeles Garcia-Criado, Anna Darnell, Fanny Turon, Virginia Hernandez-Gea, Jaume Bosch and Juan Carlos Garcia-Pagán

      Version of Record online: 28 FEB 2014 | DOI: 10.1002/hep.26904

    2. You have free access to this content
      Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats (pages 2286–2298)

      Len Verbeke, Ricard Farre, Jonel Trebicka, Mina Komuta, Tania Roskams, Sabine Klein, Ingrid Vander Elst, Petra Windmolders, Tim Vanuytsel, Frederik Nevens and Wim Laleman

      Version of Record online: 14 APR 2014 | DOI: 10.1002/hep.26939

    3. You have free access to this content
      Alpha-1-antitrypsin inhibits acute liver failure in mice (pages 2299–2308)

      Nils Jedicke, Nina Struever, Nupur Aggrawal, Tobias Welte, Michael P. Manns, Nisar P. Malek, Lars Zender, Sabina Janciauskiene and Torsten Wuestefeld

      Version of Record online: 28 APR 2014 | DOI: 10.1002/hep.27024

  9. Liver Injury/Regeneration

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Tri-iodothyronine induces hepatocyte proliferation by protein kinase a-dependent β-catenin activation in rodents (pages 2309–2320)

      Maura Fanti, Sucha Singh, Giovanna M. Ledda-Columbano, Amedeo Columbano and Satdarshan P. Monga

      Version of Record online: 14 APR 2014 | DOI: 10.1002/hep.26775

    2. You have full text access to this OnlineOpen article
      Noninvasive in vivo magnetic resonance measures of glutathione synthesis in human and rat liver as an oxidative stress biomarker (pages 2321–2330)

      John T. Skamarauskas, Fiona Oakley, Fiona E. Smith, Carlo Bawn, Michael Dunn, Daniel S. Vidler, Matthew Clemence, Peter G. Blain, Roy Taylor, Michael P. Gamcsik and Peter E. Thelwall

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.26925

  10. Liver Biology/Pathobiology

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      The COP9 signalosome is a repressor of replicative stress responses and polyploidization in the regenerating liver (pages 2331–2343)

      Martina Panattoni, Laura Maiorino, Anna Lukacs, Lorena Zentilin, Davide Mazza, Francesca Sanvito, Giovanni Sitia, Luca G. Guidotti and Ruggero Pardi

      Version of Record online: 30 APR 2014 | DOI: 10.1002/hep.27028

    2. You have free access to this content
      T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice (pages 2344–2357)

      Angélique Gougelet, Cyril Torre, Philippe Veber, Chiara Sartor, Laura Bachelot, Pierre-Damien Denechaud, Cécile Godard, Marthe Moldes, Anne-Françoise Burnol, Céline Dubuquoy, Benoit Terris, François Guillonneau, Tao Ye, Michael Schwarz, Albert Braeuning, Christine Perret and Sabine Colnot

      Version of Record online: 14 APR 2014 | DOI: 10.1002/hep.26924

    3. You have free access to this content
      GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice (pages 2358–2370)

      Irene Delgado, Manuel Carrasco, Elena Cano, Rita Carmona, Rocío García-Carbonero, Luis M. Marín-Gómez, Bernat Soria, Francisco Martín, David A. Cano, Ramón Muñoz-Chápuli and Anabel Rojas

      Version of Record online: 29 APR 2014 | DOI: 10.1002/hep.27005

    4. You have free access to this content
      NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice (pages 2371–2382)

      Keiichi Shirasaki, Keiko Taguchi, Michiaki Unno, Hozumi Motohashi and Masayuki Yamamoto

      Version of Record online: 25 APR 2014 | DOI: 10.1002/hep.27020

    5. You have free access to this content
      Novel role of nuclear receptor rev-erbα in hepatic stellate cell activation: Potential therapeutic target for liver injury (pages 2383–2396)

      Ting Li, Ashley L. Eheim, Sabine Klein, Frank E. Uschner, Amber C. Smith, Elizabeth Brandon-Warner, Sriparna Ghosh, Herbert L. Bonkovsky, Jonel Trebicka and Laura W. Schrum

      Version of Record online: 29 APR 2014 | DOI: 10.1002/hep.27049

  11. Concise Review

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
  12. Review

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Is genotype 3 of the hepatitis C virus the new villain? (pages 2403–2412)

      Nicolas Goossens and Francesco Negro

      Version of Record online: 14 APR 2014 | DOI: 10.1002/hep.26905

  13. Hepatology Elsewhere

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
      Beyond liver fibrosis: Hepatic stellate cell senescence links obesity to liver cancer by way of the microbiome (pages 2413–2415)

      Nicholas A. Shackel, Mathew A. Vadas, Jennifer R. Gamble and Geoffrey W. McCaughan

      Version of Record online: 9 APR 2014 | DOI: 10.1002/hep.26932

    2. You have free access to this content
  14. Clinical Observations in Hepatology

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
  15. Correspondence

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Rapid Communication
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Concise Review
    13. Review
    14. Hepatology Elsewhere
    15. Clinical Observations in Hepatology
    16. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Reply (page 2424)

      Brian L. Pearlman and Carole M. Ehleben

      Version of Record online: 28 APR 2014 | DOI: 10.1002/hep.26777

    5. You have free access to this content
    6. You have free access to this content
      Reply (pages 2425–2426)

      Markus Peck-Radosavljevic, Wolfgang Sieghart, Florian Hucke and for the Vienna HCC Study Group

      Version of Record online: 4 APR 2014 | DOI: 10.1002/hep.26765

    7. You have free access to this content
      Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir (page 2426)

      Véronique Loustaud-Ratti, Paul Carrier, Chanlina Vong and Marie Essig

      Version of Record online: 14 APR 2014 | DOI: 10.1002/hep.26730

    8. You have free access to this content
      Reply (page 2427)

      Stuart C Gordon, Eduardo Bruno Martins and Leland J. Yee

      Version of Record online: 14 APR 2014 | DOI: 10.1002/hep.26902

    9. You have free access to this content
    10. You have free access to this content
    11. You have free access to this content
      Reply (pages 2428–2429)

      Christophe Bureau and Jean-Pierre Vinel

      Version of Record online: 14 APR 2014 | DOI: 10.1002/hep.26966

SEARCH

SEARCH BY CITATION